LindsayMarieHannanMD

PubMed

• Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study.
  Michael Li, Lindsay M Hannan, Lipika Goyal, Andrea G Bocobo, Anna L Parks
  Therapeutic Advances in Medical Oncology. 2024-01-01
• Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malign...
  Stacey A Cohen, Susan Veleber, Jonathan Siman, Katherine A Guthrie, Kerry McMillen
  Contemporary Clinical Trials. 2023-08-01
• 16 citations
  KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.
  Adam C Diehl, Lindsay M Hannan, David B Zhen, Andrew L Coveler, Gentry King
  The Oncologist. 2022-12-09

Lectures

• Clinical predictors of progression of a hepatic lesion from Li-RADS (LR) 3 to LR5 among patients (pts) at risk of hepatocellular carcinoma (HCC). 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
• Clinical predictors of radiographic progression of a hepatic lesion from Li-RADS 3 to Li-RADS 5 among a population of individuals at high risk of hepatocellular carcin... 
  2019 ASCO Annual Meeting - 6/1/2019
• A retrospective analysis of clinical outcomes among patients with infiltrative hepatocellular carcinoma (iHCC): A single institution study. 
  2019 ASCO Annual Meeting - 6/1/2019
• Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell TherapyClinically Relevant Abstract 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all